Eugene Major

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Eugene (Gene) O. Major, PhD, is a senior investigator at the National Institute of Neurological Disorders and Stroke (NINDS), a division of the United States National Institutes of Health (NIH).

He has a research interest in progressive multifocal leukoencephalopathy (PML), a rare and usually fatal viral disease caused by a weakened immune system, an occurrence that could follow treatment with Rituximab.

Dr Major is one of the Associate Investigators assigned to the NIH Post-Infectious ME/CFS Study.[1]

Notable studies[edit | edit source]

  • 2009, Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project[2] (Full text)
  • 2010, Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies[3]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. https://www.cdc.gov/cdcgrandrounds/pdf/archives/2016/feb2016.pdf
  2. Carson, K. R., Evens, A.M., Richey, E. A., Habermann, T. M., Focosi,D., Seymour, J. F., … Bennett, C. L. (2009). Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood, 113(20), 4834–4840. http://doi.org/10.1182/blood-2008-10-186999
  3. Major EO. (2010). Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies. Annu Rev Med. 2010;61:35-47. doi: 10.1146/annurev.med.080708.082655.